Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP645603.RAgXf2U1w9ZDjYdZST5_FVM8b9-_C0J6ftqXdcufzs2_k130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP645603.RAgXf2U1w9ZDjYdZST5_FVM8b9-_C0J6ftqXdcufzs2_k130_assertion type Assertion NP645603.RAgXf2U1w9ZDjYdZST5_FVM8b9-_C0J6ftqXdcufzs2_k130_head.
- NP645603.RAgXf2U1w9ZDjYdZST5_FVM8b9-_C0J6ftqXdcufzs2_k130_assertion description "[Overexpression of the cytokine transforming growth factor-beta 2 (TGF-beta2) is a hallmark of various malignant tumors including pancreatic carcinoma, malignant glioma, metastasizing melanoma, and metastatic colorectal carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP645603.RAgXf2U1w9ZDjYdZST5_FVM8b9-_C0J6ftqXdcufzs2_k130_provenance.
- NP645603.RAgXf2U1w9ZDjYdZST5_FVM8b9-_C0J6ftqXdcufzs2_k130_assertion evidence source_evidence_literature NP645603.RAgXf2U1w9ZDjYdZST5_FVM8b9-_C0J6ftqXdcufzs2_k130_provenance.
- NP645603.RAgXf2U1w9ZDjYdZST5_FVM8b9-_C0J6ftqXdcufzs2_k130_assertion SIO_000772 18084956 NP645603.RAgXf2U1w9ZDjYdZST5_FVM8b9-_C0J6ftqXdcufzs2_k130_provenance.
- NP645603.RAgXf2U1w9ZDjYdZST5_FVM8b9-_C0J6ftqXdcufzs2_k130_assertion wasDerivedFrom befree-2016 NP645603.RAgXf2U1w9ZDjYdZST5_FVM8b9-_C0J6ftqXdcufzs2_k130_provenance.
- NP645603.RAgXf2U1w9ZDjYdZST5_FVM8b9-_C0J6ftqXdcufzs2_k130_assertion wasGeneratedBy ECO_0000203 NP645603.RAgXf2U1w9ZDjYdZST5_FVM8b9-_C0J6ftqXdcufzs2_k130_provenance.